Pamine Related Published Studies
Well-designed clinical trials possibly related to Pamine (Methscopolamine)
[Usefulness of pirenzepine in the study of the upper digestive tract and the large intestine with double contrast media: comparison with scopolamine methylbromide] [1996.12]
Pirenzepine versus scopolamine methyl bromide in double-contrast barium enema study of large bowel. [1996.07]
Oral retention of glucose at pharmacologically reduced salivary flow in man. [1994.06]
Usefulness and safety of pirenzepine in double-contrast study of upper gastrointestinal tract: comparison with scopolamine methylbromide. [1994.05]
Suppression of sleep-induced growth hormone secretion by anticholinergic agent abolishes dawn phenomenon. [1988.02]
Other research related to Pamine (Methscopolamine)
Methscopolamine bromide blocks hypothalamic-stimulated release of growth hormone in ewes. [1997.05]
The muscarine antagonist methscopolamine and the NMDA antagonist AP-5 injected unilaterally into the nucleus accumbens cause mice to rotate in opposite directions. [1995]
Dorsal striatal mechanisms involved in the dopamine D2 receptor-mediated potentiation of apomorphine-induced jaw movements. [1994.01.24]
Seizure promotion by D1 agonists does not correlate with other dopaminergic properties. [1993]
Other possibly related research studies
Hemodynamic consequences of chronic parasympathetic blockade with a peripheral muscarinic antagonist. [2007.08]
Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents. [2007.01]
Advantages for transdermal over oral oxybutynin to treat overactive bladder: Muscarinic receptor binding, plasma drug concentration, and salivary secretion. [2006.03]
Antiepileptic effect of acylpolyaminetoxin JSTX-3 on rat hippocampal CA1 neurons in vitro. [2005.06.28]
Effects of saw palmetto extract on micturition reflex of rats and its autonomic receptor binding activity. [2005.04]
Anticonvulsant activity of ginseng on seizures induced by chemical convulsants. [2005.01]
Hypothalamic regulation of pancreatic secretion is mediated by central cholinergic pathways in the rat. [2003.10.15]
Intestinal serotonin acts as paracrine substance to mediate pancreatic secretion stimulated by luminal factors. [2001.10]
Substance P and its transglutaminase-synthesized spermine derivative elicit yawning behavior via nitric oxide in rats. [2001.09]
Heart-lung interactions: the sigh and autonomic control in the bronchial and coronary circulations. [2000.12]
Lateral parabrachial lesions impair intraperitoneal but not intraventricular methylscopolamine-induced taste aversion learning. [2000.07.14]
Anisocoria associated with the medical treatment of irritable bowel syndrome. [2000.06]
Impaired atrial M(2)-cholinoceptor function in obesity-related hypertension. [1999.11]
Cholinergic blockade inhibits gastro-oesophageal reflux and transient lower oesophageal sphincter relaxation through a central mechanism. [1999.05]
Central cardiovascular effects of tacrine in the conscious dog: a role for catecholamines and vasopressin release. [1998.05.08]
Effect of sequence of administration on the pharmacokinetic interaction between the anticholinergic drug biperiden and [3H]quinuclidinyl benzylate or [3H]N-methylscopolamine in rats. [1998.02]
Effects of scopolamine and hippocampal lesions on negative patterning discrimination performance in rats. [1997.12]
Characterization of an esophagocardiovascular reflex in the rat. [1997.06]
Butylthio[2.2.2] (NNC 11-1053/LY297802): an orally active muscarinic agonist analgesic. [1997.05]
Effects of central muscarinic-1 receptor stimulation on blood pressure regulation. [1997.03]
Suppression of the rat micturition reflex by imipramine. [1997.02]
Power spectral analysis of heart-rate variability reflects the level of cardiac autonomic activity in rabbits. [1996.04.20]
Amino acid side chains that define muscarinic receptor/G-protein coupling. Studies of the third intracellular loop. [1996.02.09]
Muscarinic receptors and insulin concentration in the rat pancreas after chronic alcohol intake and cholinergic stimulation. [1996.01]
Ventricular, but not atrial, M2-muscarinic receptors increase in the canine pacing-overdrive model of heart failure. [1996.01]
A potential strategy for decreasing milk production in the ewe at weaning using a growth hormone release blocker. [1995.07]
Sympathetic regulation in rabbits with heart failure: experience using power spectral analysis of heart rate variability. [1995.06]
Clozapine injected into the nucleus accumbens potentiates apomorphine-induced jaw movements. [1994.09.01]
Further evidence for a functional dorsal-ventral division of the rat striatum: GABAergic involvement in oral movements. [1993.08.03]
Effects of scopolamine on autonomic profiles underlying motion sickness susceptibility. [1993.01]
Regulation of central muscarinic receptors after cholinesterase inhibition: effect of clonidine. [1993]
The effects of p-chlorophenylalanine-induced serotonin synthesis inhibition and muscarinic blockade on the performance of rats in a 5-choice serial reaction time task. [1992.10.31]
Cholinergic blockade and response timing in rats. [1992]
Peripheral-type benzodiazepine receptors in anxiety disorders. [1991.12]
Inefficient muscarinic transduction in cardiomyopathic Syrian hamsters. [1991.11]
Anti-muscarinic drug effects in a swim-to-platform test: dose-response relations. [1991.08.29]
An analysis of lymphocyte 3H-N-methyl-scopolamine binding in neurological patients. Evidence of altered binding in Alzheimer's disease. [1991.08]
Long-term suppression in mice of the development of complementary memory storage sites: effect of a muscarinic antagonist. [1991.07]
Scopolamine differentially disrupts the behavior of male and female Wistar rats in a delayed nonmatching to position procedure. [1990.04]
Effects of intravenous AVP on cardiac output, mesenteric hemodynamics, and splanchnic nerve activity. [1989.08]
Prevention by prostaglandins of caerulein-induced pancreatitis in rats. [1989.05]
Indomethacin-induced gastric antral ulcers in hamsters. [1988.10]
Allosteric stabilization of 3H-N-methylscopolamine binding in guinea-pig myocardium by an antidote against organophosphate intoxication. [1988.09]
[Implication of spinal catecholaminergic pathways in sympathetic pressor responses] [1988.06]
Effects of scopolamine on repeated acquisition of radial-arm maze performance by rats. [1988.03]
Muscarinic cholinergic receptor subtypes in hippocampus in human cognitive disorders. [1988.03]
Modelling dementia: effects of scopolamine on memory and attention. [1988]
Magnesium-induced catharsis in chicks. [1987.11]
Evidence that hyperglycemia increases muscarinic binding in pancreatic islets of the rat. [1987.11]
Contraindication for osmotic mini-pump in the abdominal cavity to study muscarinic cholinergic control of pancreatic enzyme secretion and muscarinic receptors. [1986.10]
Muscarinic receptor antagonism of the nucleus accumbens core causes avoidance to flavor and spatial cues. [2007.12]
|
